Drug Hunter is a B2B subscription scientific intelligence platform for biotech and pharmaceutical R&D scientists that empowers them to discover the medicines of the future. We serve many of the world’s leading biotech and pharmaceutical organizations, including Dow 30 and S&P 500 companies.
Are you looking to launch your IT career on a team that will actually invest in you? We’re looking for an IT Support Specialist to be the friendly first point of contact for our fully remote team, keeping everyone’s devices, accounts, and tools running smoothly. This is an entry-level role built for a bright, driven person who may not have all the experience yet but has the ability to pick things up fast and grow into a well-rounded technologist.
We’re a small, remote-first company that depends on our tools working well and our people getting fast, patient help when they don’t. You’ll work closely with the rest of the team, with plenty of mentorship and room to grow. We value curiosity, reliability, and a genuine willingness to help. We’ll give you real ownership as you get comfortable, rather than making you wait years to earn it.
Requirements
Benefits
Benefits
Drug Hunter provides industry-leading benefits, including the following:

Drug Hunter™ is an essential subscription service for R&D-focused organizations turning molecules into medicines.
Every day, drug discovery strategies, tactics, challenges and solutions are disclosed, but the knowledge is fragmented across journals, conferences, patents, databases, news, company reports, filings and endless other sources, making it challenging to find and apply.
Drug Hunter’s experts keep you current by connecting the dots, distilling industry lessons from thousands of sources into a one-of-a-kind searchable platform for drug discovery knowledge you can apply to make better decisions and solve critical discovery challenges.
Founded and run by a team of industry scientists, Drug Hunter now serves >200 innovative institutions worldwide including top pharma and biotech companies, investors, and non-profits.